Drug Profile
Research programme: daunorubucin analogues - Menarini
Alternative Names: Daunorubucin analogues research programme - MenariniLatest Information Update: 29 Jun 2007
Price :
$50
*
At a glance
- Originator Menarini
- Class
- Mechanism of Action DNA cross linking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 Feb 2004 Preclinical trials in Cancer in Italy (unspecified route)